药物涂层球囊血管成形术治疗慢性肢体威胁性缺血膝下病变:PRIME-WIFI 研究的 6 个月结局
PRIME-WIFI 前瞻性注册研究纳入 10 中心 300 例慢性肢体威胁性缺血(CLTI)患者,分析膝下动脉药物涂层球囊(DCB)血管成形术的 6 个月结局。主要结局无主要不良事件(MAE)生存率为 86.353%,无截肢生存率 90.318%,主要截肢、全因死亡和临床驱动靶肢体再干预的自由率分别为 96.429%、93.480% 和 95.079%。作者结论认为膝下 DCB 血管成形术早期疗效和安全性可接受。
要点
- 6 个月无 MAE 生存率 86.353%,无截肢生存率 90.318%。
- 主要截肢、全因死亡、CD-TLR 自由率分别为 96.429%、93.480%、95.079%。
- 慢性肾功能不全、COPD、Rutherford 分级和术后膝下流出道评分是 6 个月内 MAE 的独立危险因素。
核心结论
- 在 CLTI 患者中,膝下病变 DCB 血管成形术可获得可接受的早期疗效和安全性,作者指出需要真实世界对比研究。
研究设计与样本
- 10 中心前瞻性注册研究 PRIME-WIFI,连续纳入 300 例因膝下动脉病变接受 DCB 血管成形术的 CLTI 患者(女性 33.000%),分析 6 个月随访数据。
主要发现
- 共对 312 条肢体的 409 处膝下病变行 DCB 治疗,其中 54.167% 的肢体为孤立性膝下病变。
- 术后 6 个月(随访率 85.000%)Kaplan-Meier 分析显示无 MAE 生存率 86.353%,无截肢生存率 90.318%。
- 主要截肢、全因死亡和 CD-TLR 的自由率分别为 96.429%、93.480% 和 95.079%。
- 6 个月随访时 83.590% 的患者显示持续性临床改善,生活质量评分从术前 2.327±1.109 改善至 4.902±1.388(p<0.001)。
- 慢性肾功能不全、慢性阻塞性肺疾病、Rutherford 分级和术后膝下流出道评分是 6 个月内 MAE 的独立危险因素。
关键数值与推荐
- 主要结局无 MAE 定义为免于主要截肢、全因死亡和临床驱动靶肢体再干预(CD-TLR)的复合终点。
- 6 个月无 MAE 生存率 86.353%,无截肢生存率 90.318%,主要截肢自由率 96.429%,全因死亡自由率 93.480%,CD-TLR 自由率 95.079%。
- 6 个月持续性临床改善率 83.590%,生活质量评分 4.902±1.388 对比术前 2.327±1.109(p<0.001)。
- 慢性肾功能不全、慢性阻塞性肺疾病、Rutherford 分级和术后膝下流出道评分是 6 个月内 MAE 的独立危险因素。
临床怎么用
- 作者结论认为膝下 DCB 血管成形术在 CLTI 中早期疗效和安全性可接受;本研究中无患者发生 DCB 相关术中远端栓塞。
局限性
- 作者指出需要真实世界对比研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To evaluate 6-month outcomes of drug-coated balloon (DCB) angioplasty of infrapopliteal lesions in patients with chronic limb-threatening ischemia (CLTI). METHODS: We analyzed 6-month follow-up data from the 10-center PRIME-WIFI prospective registry on 300 consecutive patients (33.000% female) with CLTI who underwent DCB angioplasty for infrapopliteal arterial lesions. The primary outcome was freedom from major adverse event (MAE), a composite of major amputation, all-cause death, and clinically-driven target limb reintervention (CD-TLR). Secondary outcomes included amputation-free survival (AFS), freedom from each primary outcome component, primary sustained clinical improvement, and quality of life (QOL) score. Independent risk factors of MAE were determined using Cox proportional hazards regression analysis. RESULTS: A total of 409 infrapopliteal lesions in 312 limbs were treated with DCB, with 54.167% of the limbs being treated for isolated infrapopliteal lesions. By Kaplan-Meier analysis, at 6 months post- procedure (follow-up rate, 85.000%), freedom from MAE was 86.353%; AFS was 90.318%; and freedom from major amputation, all-cause death, and CD-TLR were 96.429%, 93.480%, and 95.079%, respectively. At 6-month follow-up, 83.590% of patients showed primary sustained clinical improvement, and QOL score (4.902±1.388) improved compared with that before procedure (2.327±1.109; p<0.001). Chronic renal insufficiency, chronic obstructive pulmonary disease, Rutherford grade, and postoperative infrapopliteal runoff score were independent risk factors for MAE within 6 months. CONCLUSION: In CLTI, DCB angioplasty of infrapopliteal lesions yields acceptable early efficacy and safety.Clinical ImpactThis study evaluated the 6-month outcomes of DCB angioplasty in infrapopliteal lesions in CLTI patients by analyzing multicenter prospective data, showing that infrapopliteal DCB angioplasty can be performed with acceptable freedom from MAE rate, amputation-free survival rate, freedom from major amputation rate, survival rate, and freedom from CD-TLR rate. No patient experienced DCB-related intraoperative distal embolism. Chronic renal insufficiency, chronic obstructive pulmonary disease, Rutherford grade and postoperative infrapopliteal runoff score were independent risk factors for MAE within 6 months. Comparative real-world studies are needed.
引用
- Guo J, Ye M, Zhang W, et al. Drug-Coated Balloon Angioplasty of Infrapopliteal Lesions in Chronic Limb-Threatening Ischemia: Six-month Outcomes of PRIME-WIFI. J Endovasc Ther. 2023. PMID: 37919946. doi:10.1177/15266028231208646
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。